AI chatbots outperform doctors in empathy and readability for cancer-related questions, study finds

FHS
May 21, 2024
3:22 am

Study found that AI chatbots provided higher empathy, response quality, and readability in answers to cancer-related inquiries compared to licensed physicians.

One biotech is looking to lessen antipsychotic-induced weight gain, despite new entrants

Response Pharmaceuticals believes its experimental drug can lessen the persistent weight gain associated with antipsychotics. In a new pilot study, the company assessed RDX-002 in

November 6, 2024

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 27, 2024

SGLT2 Hesitance; Furosemide’s Indication Grows; Legal Fight Over Entresto Generic

From 2022 to 2023, uptake of SGLT2 inhibitors was low in patients with a class Ia recommendation. (Journal of the American College of Cardiology) In

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.